The guidelines issued by the European Society for human Reproduction and Embryology and the American Society for reproductive medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration

Hormones

Volumn 12, Issue 2, 2013, Pages 192-200

  Panidis, Dimitrios ^a   Tziomalos, Konstantinos ^b   Papadakis, Efstathios ^a   Kandaraki, Eleni A ^a   Katsikis, Ilias ^a  

^a Aristotle University of Thessaloniki   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Anovulation; Clomiphene citrate; Metformin; Polycystic ovary syndrome; Thessaloniki ESHRE ASRM sponsored PCOS consensus workshop group

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; METFORMIN; PLACEBO;

ABDOMINAL PAIN; ANOVULATION; BODY MASS; DIARRHEA; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; DYSPEPSIA; EUROPE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FLATULENCE; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LOW DRUG DOSE; MEDICAL SOCIETY; MONOTHERAPY; MORBIDITY; MULTIPLE CYCLE TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTION; REVIEW; TASTE DISORDER;

ANIMALS; CLOMIPHENE; DRUG THERAPY, COMBINATION; ESTROGEN ANTAGONISTS; EUROPE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; INSULIN RESISTANCE; METFORMIN; OVARIAN HYPERSTIMULATION SYNDROME; OVERWEIGHT; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; SOCIETIES, SCIENTIFIC; UNITED STATES;

EID: 84880728582     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1403     Document Type: Review

References (76)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al, 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84: 4006-4011.
2. Nestler JE, 2008 Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med 358: 47-54.
3. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R, 2011 Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7: 219-231.
4. Dunaif A, Segal KR, Futterweit W, Dobrjansky A, 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174.
5. Morales AJ, Laughlin GA, Bützow T, Mahehwari H, Baumann G, Yen SS, 1996 Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 81: 2854-2864.
6. Khattab S, Mohsen IA, Aboul Foutouh I, et al, 2011 Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecol Endocrinol 27: 789-793.
7. Maymone AC, Baillargeon JP, Ménard J, Ardilouze JL, 2011 Oral hypoglycemic agents for gestational diabetes mellitus? Expert Opin Drug Saf 10: 227-238.
8. Homburg R, 2006 Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 20: 281-292.
9. Ijäs H, Vääräsmäki M, Morin-Papunen L, et al, 2011 Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 118: 880-885.
10. Nicholson W, Baptiste-Roberts K, 2011 Oral hypoglycaemic agents during pregnancy: The evidence for effectiveness and safety. Best Pract Res Clin Obstet Gynaecol 25: 51-63.
11. Gandhi P, Bustani R, Madhuvrata P, Farrell T, 2012 Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact? Eur J Obstet Gynecol Reprod Biol 160: 147-150.
12. Silva JC, Fachin DR, Coral ML, Bertini AM, 2012 Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med 40: 225-228.
13. Morin-Papunen L, Rantala AS, Unkila-Kallio L, et al, 2012 Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 97: 1492-1500.
14. Diamanti-Kandarakis E, Panidis D, 2007 Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 67: 735-742.
15. Jonard S, Dewailly D, 2004 The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10: 107-117.
16. Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA, 2001 Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 86: 1318-1323.
17. Willis D, Mason H, Gilling-Smith C, Franks S, 1996 Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulose cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81: 302-309.
18. Salih SM, Jamaluddin M, Salama SA, Fadl AA, Nagamani M, Al-Hendy A, 2008 Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome. Fertil Steril 89: 1414-1421.
19. Dumesic DA, Schramm RD, Peterson E, Paprocki AM, Zhou R, Abbott DH, 2002 Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab 87: 1111-1119.
20. Qiao J, Feng HL, 2011 Extra-and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturationand embryo developmental competence. Hum Reprod Update 17: 17-33.
21. Legro RS, 2000 The genetics of obesity. Lessons for polycystic ovary syndrome. Ann N Y Acad Sci 900: 193-202.
22. Cardozo E, Pavone ME, Hirshfeld-Cytron JE, 2011 Metabolic syndrome and oocyte quality. Trends Endocrinol Metab 22: 103-109.
23. Brewer CJ, Balen AH, 2010 The adverse effects of obesity on conception and implantation. Reproduction 140: 347-364.
24. Bellver J, Martínez-Conejero JA, Labarta E, et al, 2011 Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome. Fertil Steril 95:2335-2341, 2341.e1-8.
25. Nestler JE, Jakubowicz DJ, 1996 Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335: 617-623.
26. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R, 1998 Effects of metformin on spontaneous and clomipheneinduced ovulation in the polycystic ovary syndrome. N Engl J Med 338: 1876-1880.
27. Palomba S, Orio F, Jr, Falbo A, et al, 2005 Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 4068-4074.
28. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE, 2002 Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 87: 524-529.
29. Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM, 2004 Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 19: 1734-1740.
30. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2008 Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23: 462-477.
31. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2008 Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89: 505-522.
32. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J, 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22: 141-146.
33. Legro RS, Kunselman AR, Dodson WC, Dunaif A, 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84: 165-169.
34. Faloia E, Canibus P, Gatti C, et al, 2004 Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest 27: 424-429.
35. Attaoua R, Ait El Mkadem S, Radian S, et al, 2008 FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. Biochem Biophys Res Commun 373: 230-234.
36. Legro RS, Barnhart HX, Schlaff WD, et al; Cooperative Multicenter Reproductive Medicine Network, 2007 Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356: 551-566.
37. Panidis D, Farmakiotis D, 2007 Treatment of infertility in the polycystic ovary syndrome. N Engl J Med 356: 1999; author reply 2000-2001.
38. Johnson N, 2011 Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome-a meta-analysis of randomised trials. Aust N Z J Obstet Gynaecol 51: 125-129.
39. Jungheim ES, Odibo AO, 2010 Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents. Fertil Steril 94: 2659-2664.
40. Johnson NP, Stewart AW, Falkiner J, et al; REACT-NZ (REproduction And Collaborative Trials in New Zealand), a multi-centre fertility trials group, 2010 PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene. Hum Reprod 25: 1675-1683.
41. Johnson NP, Bontekoe S, Stewart AW, 2011 Analysis of factors predicting success of metformin and clomiphene treatment for women with infertility owing to PCOSrelated ovulation dysfunction in a randomised controlled trial. Aust N Z J Obstet Gynaecol 51: 252-256.
42. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH, 2012 Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 5: CD003053.
43. Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F, 2006 Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 332: 1485.
44. Homburg R, 2009 Androgen circle of polycystic ovary syndrome. Hum Reprod 24: 1548-1555.
45. Moody J, ed. 2004 Fertility assessment and treatment for people with fertility problems. National Institute of Clinical Excellence Guideline. London: RCOG Press 58-59.
46. Abu Hashim H, Wafa A, El Rakhawy M, 2011 Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: a randomised controlled trial. Gynecol Endocrinol 27: 190-196.
47. Moll E, van der Veen F, van Wely M, 2007 The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod Update 13: 527-537.
48. Kashyap S, Wells GA, Rosenwaks Z, 2004 Insulinsensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Hum Reprod 19: 2474-2483.
49. Cheng J, Lv J, Li CY, Xue Y, Huang Z, Zheng W, 2010 Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome. J Int Med Res 38: 1250-1258.
50. National Collaborating Centre for women's and children's Health/National Institute for Clinical Excellence, 2004 Fertility: assessment and treatment for people with fertility problems. London, UK: Clinical Guideline 11, RCOG Press.
51. Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E, 2009 Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev 4: CD002249.
52. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE, 2011 Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75: 310-315.
53. Kocak M, Caliskan E, Simsir C, Haberal A, 2002 Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 77: 101-106.
54. Malkawi HY, Qublan HS, 2002 The effect of metformin plus clomiphene citrate onovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome. Saudi Med J 23: 663-666.
55. Siebert TI, Kruger TF, Steyn DW, Nosarka S, 2006 Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Fertil Steril 86: 1432-1437.
56. Creanga AA, Bradley HM, McCormick C, Witkop CT, 2008 Use of metformin in polycystic ovary syndrome: a meta-analysis. Obstet Gynecol 111: 959-968.
57. Attia GR, Rainey WE, Carr BR, 2001 Metformin directly inhibits androgen production in human thecal cells. Fertil Steril 76: 517-524.
58. la Marca A, Morgante G, Paglia T, Ciotta L, Cianci A, De Leo V, 1999 Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome. Fertil Steril 72: 985-989.
59. Billa E, Kapolla N, Nicopoulou SC, et al, 2009 Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome. Gynecol Endocrinol 25: 427-434.
60. Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F, 2004 Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomized controlled trial. BMJ 328: 192.
61. Cristello F, Cela V, Artini PG, Genazzani AR, 2005 Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome. Gynecol Endocrinol 21: 340-352.
62. Ratts VS, Pauls RN, Pinto AB, Kraja A, Williams DB, Odem RR, 2007 Risk of multiple gestation after ovulation induction in polycystic ovary syndrome. J Reprod Med 52: 896-900.
63. Tso LO, Costello MF, Albuquerque LE, Andriolo RB, Freitas V, 2009 Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2: CD006105.
64. Palomba S, Falbo A, Carrillo L, et al; METformin in High Responder Italian Group, 2011 Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropinstimulated in vitro fertilization cycles: a randomized, controlled trial. Fertil Steril 96: 1384-1390.e4.
65. Zain MM, Jamaluddin R, Ibrahim A, Norman RJ, 2009 Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril 91: 514-521.
66. Morin-Papunen LC, Koivunen RM, Ruokonen A, Martikainen HK, 1998 Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril 69: 691-696.
67. Gleicher N, Barad DH, 2011 Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 9: 67.
68. Bruno RV, de Avila MA, Neves FB, Nardi AE, Crespo CM, Sobrinho AT, 2007 Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference. Fertil Steril 88: 510-512.
69. Weerakiet S, Sophonsritsuk A, Lertvikool S, Satirapot C, Leelaphiwat S, Jultanmas R, 2011 Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome. J Obstet Gynaecol Res 37: 1229-1237.
70. Gonen Y, Casper RF, 1990 Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5: 670-674.
71. Wu HH, Wang NM, Cheng ML, Hsieh JN, 2007 A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility. Gynecol Endocrinol 23: 76-81.
72. Vanky E, Stridsklev S, Heimstad R, et al, 2010 Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 95: E448-455.
73. Meis PJ, Klebanoff M, Thom E, et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, 2003 Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348: 2379-2385.
74. Jensen A, Sharif H, Frederiksen K, Kjaer SK, 2009 Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ 338: b249.
75. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG, 1994 Ovarian tumors in a cohort of infertile women. N Engl J Med 331: 771-776.
76. Diamanti-Kandarakis E, 2012 Reproductive endocrinology: Infertility treatment in PCOS-is metformin in from the cold? Nat Rev Endocrinol 8: 328-330.